<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>生物制药小编 | wechat-feeds</title><link>http://MzU3Nzg4NzQyNg.favicon.privacyhide.com/favicon.ico</link><description>“新起点，再出发”——生物医药小编与您共同关注生物制药行业热点。</description><managingEditor> (hellodword)</managingEditor><pubDate>Tue, 20 Apr 2021 10:09:07 +0800</pubDate><image><url>http://MzU3Nzg4NzQyNg.favicon.privacyhide.com/favicon.ico</url><title>生物制药小编 | wechat-feeds</title><link>http://MzU3Nzg4NzQyNg.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>Self Renew｜GPCR相关抗体的开发——不再单调的MOA</title><link>https://mp.weixin.qq.com/s/nDLiO8RNFjJiOo_klNvGrA</link><description></description><content:encoded><![CDATA[Self Renew｜GPCR相关抗体的开发——不再单调的MOA]]></content:encoded><pubDate>Tue, 20 Apr 2021 08:47:39 +0800</pubDate></item><item><title>本周六盛大开启 | 2021PVcon生物制品安全与工艺大会</title><link>https://mp.weixin.qq.com/s/tZwTJfeZfThvnO8DdtKhVA</link><description></description><content:encoded><![CDATA[本周六盛大开启 | 2021PVcon生物制品安全与工艺大会]]></content:encoded><pubDate>Tue, 20 Apr 2021 08:47:39 +0800</pubDate></item><item><title>FDA是如何审评药品的</title><link>https://mp.weixin.qq.com/s/UFC6HSmwV9b9dxv76AXUTg</link><description></description><content:encoded><![CDATA[FDA是如何审评药品的]]></content:encoded><pubDate>Tue, 20 Apr 2021 08:47:39 +0800</pubDate></item><item><title>Schlafen 5：治疗胰腺癌的新靶点</title><link>https://mp.weixin.qq.com/s/xo-S9GPev6slQDSRK9Ui7A</link><description></description><content:encoded><![CDATA[Schlafen 5：治疗胰腺癌的新靶点]]></content:encoded><pubDate>Sun, 18 Apr 2021 20:32:16 +0800</pubDate></item><item><title>Twist Bioscience「谱写未来-亚太区专场」线上会议诚邀您参加</title><link>https://mp.weixin.qq.com/s/mmfUvuqRnis_2WbPwONSdA</link><description></description><content:encoded><![CDATA[Twist Bioscience「谱写未来-亚太区专场」线上会议诚邀您参加]]></content:encoded><pubDate>Sun, 18 Apr 2021 20:32:16 +0800</pubDate></item><item><title>2021复旦大学基础医学院招聘开始啦！</title><link>https://mp.weixin.qq.com/s/tbhlQy0CNE6hLQHZSBenDg</link><description></description><content:encoded><![CDATA[2021复旦大学基础医学院招聘开始啦！]]></content:encoded><pubDate>Sun, 18 Apr 2021 20:32:16 +0800</pubDate></item><item><title>诺华（Novartis）——天价药合理且合法？</title><link>https://mp.weixin.qq.com/s/dlvvGvoibZ3IulDMRVYTBw</link><description></description><content:encoded><![CDATA[诺华（Novartis）——天价药合理且合法？]]></content:encoded><pubDate>Sat, 17 Apr 2021 19:49:00 +0800</pubDate></item><item><title>买家团火热来袭：你的渠道够强吗？</title><link>https://mp.weixin.qq.com/s/JibfojDUsS3YGGFWI9YWFA</link><description></description><content:encoded><![CDATA[买家团火热来袭：你的渠道够强吗？]]></content:encoded><pubDate>Sat, 17 Apr 2021 19:49:00 +0800</pubDate></item><item><title>做中国生物医药的忠实记录者</title><link>https://mp.weixin.qq.com/s/UouMgDdStjrP8MN-NWRE5w</link><description></description><content:encoded><![CDATA[做中国生物医药的忠实记录者]]></content:encoded><pubDate>Sat, 17 Apr 2021 19:49:00 +0800</pubDate></item><item><title>双特异性抗体：on-target off-tumor毒性及克服策略</title><link>https://mp.weixin.qq.com/s/6mUjx3lHw4KivmuA3Ff-qQ</link><description></description><content:encoded><![CDATA[双特异性抗体：on-target off-tumor毒性及克服策略]]></content:encoded><pubDate>Fri, 16 Apr 2021 19:25:47 +0800</pubDate></item><item><title>佰傲严选：亮剑吧！您的分析仪器！</title><link>https://mp.weixin.qq.com/s/V6zouh-X1N5Ibti_CFabjQ</link><description></description><content:encoded><![CDATA[佰傲严选：亮剑吧！您的分析仪器！]]></content:encoded><pubDate>Fri, 16 Apr 2021 19:25:47 +0800</pubDate></item><item><title>杨森Bipod高通量双抗开发平台</title><link>https://mp.weixin.qq.com/s/T72LX0A-8FdxZUlB0myUHg</link><description></description><content:encoded><![CDATA[杨森Bipod高通量双抗开发平台]]></content:encoded><pubDate>Thu, 15 Apr 2021 17:06:00 +0800</pubDate></item><item><title>腺相关病毒载体AAVs的快速表征分析</title><link>https://mp.weixin.qq.com/s/RKdb8UjLGzgxYA-L9Jmc5w</link><description></description><content:encoded><![CDATA[腺相关病毒载体AAVs的快速表征分析]]></content:encoded><pubDate>Thu, 15 Apr 2021 17:06:00 +0800</pubDate></item><item><title>抓住质量管理“牛鼻子“，你在哪一段？</title><link>https://mp.weixin.qq.com/s/XNKKhoJ90bKZLW27qCdYaw</link><description></description><content:encoded><![CDATA[抓住质量管理“牛鼻子“，你在哪一段？]]></content:encoded><pubDate>Thu, 15 Apr 2021 17:06:00 +0800</pubDate></item><item><title>靶向CD36：肿瘤免疫疗法的新策略</title><link>https://mp.weixin.qq.com/s/Ph7R9gxecy4UuYRNvjKSaw</link><description></description><content:encoded><![CDATA[靶向CD36：肿瘤免疫疗法的新策略]]></content:encoded><pubDate>Wed, 14 Apr 2021 16:49:28 +0800</pubDate></item><item><title>重磅︱乐纯生物与雷诺丽特签署战略合作协议</title><link>https://mp.weixin.qq.com/s/hhJtdvF9j0BTvPsCKmfdsA</link><description></description><content:encoded><![CDATA[重磅︱乐纯生物与雷诺丽特签署战略合作协议]]></content:encoded><pubDate>Wed, 14 Apr 2021 16:49:28 +0800</pubDate></item><item><title>首个适应症刚获转正，FDA又加速批准Trodelvy第二个适应症--膀胱癌</title><link>https://mp.weixin.qq.com/s/sOGICs99bE5uF4l494H6oA</link><description></description><content:encoded><![CDATA[首个适应症刚获转正，FDA又加速批准Trodelvy第二个适应症--膀胱癌]]></content:encoded><pubDate>Wed, 14 Apr 2021 16:49:28 +0800</pubDate></item><item><title>抓住质量管理“牛鼻子“，你在哪一段？</title><link>https://mp.weixin.qq.com/s/vUUqkzwpcAqz6SjWR33Hfw</link><description></description><content:encoded><![CDATA[抓住质量管理“牛鼻子“，你在哪一段？]]></content:encoded><pubDate>Wed, 14 Apr 2021 16:49:28 +0800</pubDate></item><item><title>条件激活成为新宠：辉瑞开发小分子调控活性的Cond CAR-T</title><link>https://mp.weixin.qq.com/s/AISUduwNuzb69GWWuNUJhA</link><description></description><content:encoded><![CDATA[条件激活成为新宠：辉瑞开发小分子调控活性的Cond CAR-T]]></content:encoded><pubDate>Tue, 13 Apr 2021 14:08:11 +0800</pubDate></item><item><title>火热报名中 | 2021PVcon生物制品安全与工艺大会</title><link>https://mp.weixin.qq.com/s/iBal_kGpWbJTSPkzcvDulw</link><description></description><content:encoded><![CDATA[火热报名中 | 2021PVcon生物制品安全与工艺大会]]></content:encoded><pubDate>Tue, 13 Apr 2021 14:08:11 +0800</pubDate></item></channel></rss>